Seres Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Seres Therapeutics is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is €-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 64.00K	$ 310.00K	$ 126.47M	$ -522.00K	$ 975.00K
Gross Profit	$ 64.00K	$ 310.00K	$ 126.47M	$ -522.00K	$ 975.00K
EBIT	-	$ -44.88M	$ 53.95M	$ -70.26M	$ -68.33M
EBITDA	-	$ -42.80M	$ 55.58M	$ -68.86M	$ -66.54M
Net Income Common Stockholders	$ -41.25M	$ -48.89M	$ 46.55M	$ -71.17M	$ -68.80M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 127.97M	$ 169.91M	$ 229.52M	$ 106.54M	$ 181.34M
Total Assets	$ 358.60M	$ 367.70M	$ 406.39M	$ 270.19M	$ 348.78M
Total Debt	$ 213.94M	$ 212.28M	$ 212.92M	$ 162.71M	$ 162.59M
Net Debt	$ 85.97M	$ 42.37M	$ -16.60M	$ 56.17M	$ -18.75M
Total Liabilities	$ 403.46M	$ 382.82M	$ 383.77M	$ 318.06M	$ 338.00M
Stockholders Equity	$ -44.86M	$ -15.12M	$ 22.61M	$ -47.87M	$ 10.78M
Cash Flow	-
Free Cash Flow	-	$ -61.05M	$ 64.75M	$ -80.65M	$ -56.35M
Operating Cash Flow	$ -47.50M	$ -59.26M	$ 65.98M	$ -76.58M	$ -52.89M
Investing Cash Flow	$ -877.00K	$ -1.80M	$ 10.52M	$ 2.74M	$ 5.93M
Financing Cash Flow	$ 6.43M	$ 1.44M	$ 58.18M	$ 5.66M	$ 4.60M

Currency in USD

Seres Therapeutics Earnings and Revenue History

Income Statement >

Seres Therapeutics Debt to Assets

Balance Sheet >

Seres Therapeutics Cash Flow

Cash Flow >

Seres Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing